Top Story
Cannabis Equities Sunday August 23 2026 Evening Preview Final Full Trading Week of August Sets Stage for Q3 Earnings Acceleration and Schedule III Catalyst Window
TL;DR: Cannabis equities head into the final full trading week of August 2026 with Q3 earnings season approaching and Schedule III federal rescheduling advancing through
Top Movers
Latest Analysis
Jushi Holdings JUSHF Tuesday August 25 2026 Evening Analysis Pennsylvania and Virginia Multi-State Retail Depth Position Overlooked Mid-Cap MSO for Second-Half 2026 Operational Leverage Recovery
TL;DR: Jushi Holdings (JUSHF) enters the back half of August 2026 with a retail portfolio concentrated in Pennsylvania and Virginia, two of the most structurally
Canopy Growth CGC Tuesday August 25 2026 Midday Analysis Cost Rationalization Progress and International Medical Cannabis Revenue Define Q3 2026 Profitability Trajectory for Canadian LP
TL;DR: Canopy Growth continues executing its multi-year restructuring plan, with Q3 2026 results expected to reflect the compounding benefits of cost rationalization, non-core asset divestitures,
Cresco Labs CRLBF Tuesday August 25 2026 Midday Analysis Illinois MSO Core Market Efficiency and Wholesale Distribution Scale Define Q3 2026 Margin Recovery Path
TL;DR: Cresco Labs continues to leverage its Illinois wholesale distribution infrastructure and multi-state retail density to drive incremental margin recovery heading into Q3 2026 earnings.
Verano Holdings VRNOF Tuesday August 25 2026 Morning Analysis Illinois Flagship Market Position and Multi-State Retail Density Define Durable Q3 2026 Free Cash Flow Outlook
TL;DR: Verano Holdings (OTC: VRNOF), one of the largest vertically integrated multi-state operators in the US cannabis market, enters Tuesday’s session with a compelling free
OrganiGram Holdings OGI Tuesday August 25 2026 Morning Analysis BAT Partnership Leverage and German Export Momentum Position Canadian LP for Improved Q3 2026 Profitability Trajectory
TL;DR: OrganiGram Holdings (TSX: OGI / NASDAQ: OGI) enters Tuesday’s session with a differentiated value proposition among publicly traded Canadian licensed producers, anchored by its
Tilray Brands TLRY Monday August 24 2026 Morning Analysis Beer Portfolio Integration and International Medical Cannabis Export Revenue Create Differentiated Q3 2026 Earnings Path
TL;DR Tilray Brands (NASDAQ: TLRY) opens the final full trading week of August positioned as one of the most structurally complex — and consequently most